Eileen Carroll

Statistics

Publications

Citations

H-Index

Active since

2007

Affiliations

Goethe University Frankfurt(Current)

The University of Texas MD Anderson Cancer Center

Eileen Carroll is an author at Goethe University Frankfurt specializing in hematologic malignancy therapy, tyrosine kinase inhibitors, and hematologic oncology.

Publications per year

2007–2007

Publications

A Phase I Study of INNO-406 in Patients with Advanced Philadelphia (Ph+) Chromosome-Positive Leukemias Who Are Resistant or Intolerant to Imatinib and Second Generation Tyrosine Kinase Inhibitors.

Hagop M. Kantarjian, Jörge E. Cortes, Philipp le Coutre et al. · Blood · 2007 · 29 citations

Medicine, Hematology, Oncology +12

A phase I study of INNO-406, a dual inhibitor of Abl and Lyn kinases, in adult patients with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) or acute lymphocytic leukemia (ALL) relapsed, refractory, or intolerant of imatinib

Adam R. Craig, Hagop M. Kantarjian, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2007 · 17 citations

Medicine, Hematology, Pharmacology +14

1–2 of 2